One hundred forty-two precore/core sequences were obtained from Gambian chronic hepatitis B virus (HBV) carriers and the predominant variants defined. The two point mutations, from A to T and G to A at nt positions 1762 and 1764 in the basic core promoter region, were found in only 7/99 (7%) of the samples where this region was sequenced. These mutations were found in both HBeAg-positive and -negative patients. The precore stop-codon mutation at nt position 1896 was found in 14/51 (27%) of HBeAg-negative samples, which is a lower prevalence rate in comparison with other parts of the world with high carrier rates. In HBeAg-positive patients the core amino acid sequences were conserved, but after seroconversion to anti-HBe significantly more ...
Spontaneous mutations of hepatitis B virus (HBV) could influence the severity of liver disease. Sinc...
Background: The study of hepatitis B virus (HBV) genomic heterogeneity has become a major issue in i...
To determine the association of precore (Pre-C)/basal core promoter (BCP) mutants with clinical outc...
Introduction In Brazil, little data exist regarding the distribution of ...
Hepatitis B virus (HBV) strains from anti-HBe positive patients often show specific mutations in the...
Background. Mutations in the precore stop codon (G1896A) and the basal core promoter (A1762T and G17...
Abstract. A retrospective study was carried out to determine the frequency of the pre-core stop codo...
<p>(A) The frequency of the major mutations found in the BCP/precore region of the HBV strains circu...
The association of precore stop codon mutation (A1896), dinucleoticle mutation (T1762/A1764) in the ...
Around 5-10% of adults infected with hepatitis B virus (HBV) develop a chronic liver disease such as...
Precore nucleotide 1896 and core promoter mutations may account for hepatitis B e antigen (HBeAg) se...
Mutations in the core promoter and precore regions are frequently found in hepatitis B e antigen (HB...
The evolution of precore stop codon mutation (A1896) and dinucleotide mutation (T1762/A1764) in the ...
WOS: 000251892800030PubMed ID: 18265656Background/Aims: The mutations in the basal core promoter and...
SummaryBackgroundThe study of hepatitis B virus (HBV) genomic heterogeneity has become a major issue...
Spontaneous mutations of hepatitis B virus (HBV) could influence the severity of liver disease. Sinc...
Background: The study of hepatitis B virus (HBV) genomic heterogeneity has become a major issue in i...
To determine the association of precore (Pre-C)/basal core promoter (BCP) mutants with clinical outc...
Introduction In Brazil, little data exist regarding the distribution of ...
Hepatitis B virus (HBV) strains from anti-HBe positive patients often show specific mutations in the...
Background. Mutations in the precore stop codon (G1896A) and the basal core promoter (A1762T and G17...
Abstract. A retrospective study was carried out to determine the frequency of the pre-core stop codo...
<p>(A) The frequency of the major mutations found in the BCP/precore region of the HBV strains circu...
The association of precore stop codon mutation (A1896), dinucleoticle mutation (T1762/A1764) in the ...
Around 5-10% of adults infected with hepatitis B virus (HBV) develop a chronic liver disease such as...
Precore nucleotide 1896 and core promoter mutations may account for hepatitis B e antigen (HBeAg) se...
Mutations in the core promoter and precore regions are frequently found in hepatitis B e antigen (HB...
The evolution of precore stop codon mutation (A1896) and dinucleotide mutation (T1762/A1764) in the ...
WOS: 000251892800030PubMed ID: 18265656Background/Aims: The mutations in the basal core promoter and...
SummaryBackgroundThe study of hepatitis B virus (HBV) genomic heterogeneity has become a major issue...
Spontaneous mutations of hepatitis B virus (HBV) could influence the severity of liver disease. Sinc...
Background: The study of hepatitis B virus (HBV) genomic heterogeneity has become a major issue in i...
To determine the association of precore (Pre-C)/basal core promoter (BCP) mutants with clinical outc...